US4184847A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of indicating rheumatoid factors
Assignee: WIDE LEIF EDVIN
•
Filing: 1977-07-25
•
Granted: 1980-01-22
•
Expires: 1997-07-25
Abstract
Abstract A method of indicating rheumatoid factors, primarily such rheumatoid factors which belong to immunoglobulin classes other than the immunoglobulin class IgM, in an aqueous sample. The sample is reacted in the presence of the complement factor C1q in non-bound form with soluble, aggregated immunoglobulin labelled with one or more analytically indicatable atoms or groups to selectively precipitate such rheumatoid factors which, in the presence of C1q, are able to precipitate aggregated immunoglobulin, whereafter the analytically indicatable atoms or groups are indicated in the precipitation phase and/or in the solution.
Inventors
- 👤 Henning R. Hallgren
- 👤 Leif E. Wide
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 01:39
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/564; Y; Y10; Y10S; Y10S436/00; Y10S436/80; Y10S436/804; Y10S436/819; Y10S436/821; Y10S436/826; Y10S436/903
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
85 words
A method of indicating rheumatoid factors in an aqueous sample of human origin, said rheumatoid factors being other than those belonging to the IgM class, said method comprising: (a) treating said sample so that there is a presence of C1q in non-bound form, (b) reacting the treated sample with soluble, aggregated immunoglobulin labelled with one or more analytically indicatable atoms or groups to selectively precipitate such rheumatoid factors, and (c) thereafter measuring indicatable atoms or groups in the precipitated phase formed and/or in the solution.
Claim 2
Independent Claim
85 words
A method of indicating rheumatoid factors in an aqueous sample of human origin, said rheumatoid factors being other than those belonging to the IgM class, said method comprising: (a) treating said sample so that there is a presence of C1q in non-bound form, (b) reacting the treated sample with soluble, aggregated immunoglobulin labelled with one or more analytically indicatable atoms or groups to selectively precipitate such rheumatoid factors, and (c) thereafter measuring indicatable atoms or groups in the precipitated phase formed and/or in the solution.
Claim 3
Dependent Claim
16 words
A method according to claim 1 wherein the labelled aggregated immunoglobulin belong to the IgG class.
Claim 4
Dependent Claim
16 words
A method according to claim 1, wherein the aqueous sample of human origin is human serum.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-01-21 | 1983-07-23 | 1984-01-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-01-21 | 1987-07-23 | 1988-01-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-01-21 | 1991-07-23 | 1992-01-22 | $7700.00 | Window Closed / Lapsed |